Literature DB >> 199328

The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat.

E B Mawer, A Reeve.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199328     DOI: 10.1007/bf02064035

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  4 in total

Review 1.  Advances in the knowledge of the metabolism of vitamin D.

Authors:  D R Fraser
Journal:  Proc Nutr Soc       Date:  1975-09       Impact factor: 6.297

2.  A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite.

Authors:  M F Holick; H F DeLuca
Journal:  J Lipid Res       Date:  1971-07       Impact factor: 5.922

3.  The regulation of rat liver calciferol-25-hydroxylase.

Authors:  M H Bhattacharyya; H F DeLuca
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

4.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

  4 in total
  4 in total

1.  1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro.

Authors:  D T Baran; M L Milne
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

2.  Vitamin D metabolism in acute and chronic cholestasis.

Authors:  R T Jung; M Davie; P Siklos; T M Chalmers; J O Hunter; D E Lawson
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

3.  Suppression of rat hepatic vitamin D-25-hydroxylase by cholecalciferol, but not by 25-hydroxy- or 1,25-dihydroxymetabolites.

Authors:  M J Bolt; S C Meredith; I H Rosenberg
Journal:  Calcif Tissue Int       Date:  1988-04       Impact factor: 4.333

4.  Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.

Authors:  B P Halloran; D D Bikle; M J Levens; M E Castro; R K Globus; E Holton
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.